Background: Imagery Rescripting (ImRs) has received increasing attention in the past decades. It proved to be effective in reducing symptoms associated with aversive memories in a range of mental disorders, including anxiety disorders, eating disorders, and posttraumatic stress disorder. Given its proposed working mechanisms, ImRs may also be a relevant treatment strategy for prolonged grief disorder (PGD), where negative appraisals, helplessness, and unmet needs play a key role as maintaining factors.

Despite the availability of various treatment approaches for patients with posttraumatic stress disorder (PTSD), some patients do not respond to these therapies, and novel treatment approaches are needed. This study investigated the efficacy of mifepristone, a glucocorticoid receptor antagonist, in treatment-resistant PTSD patients. Three patients with PTSD who were resistant to standard psychological and pharmacological treatments were prescribed mifepristone (600–1,200 mg/day) for 1 week.

Introduction. Patients with complex forms of posttraumatic stress disorder (PTSD) may benefit from schema therapy. While a small number of studies point to the effectiveness of individual schema therapy in refugees with PTSD, no evidence on group schema therapy (GST) in refugees exists. To illustrate and advocate for the use of GST in refugee patients with treatment-resistant PTSD and comorbid personality pathology, a case report is presented. 

Refugee children’s development may be affected by their parents’ war-related trauma exposure and psychopathology symptoms across a range of cognitive and affective domains, but the processes involved in this transmission are poorly understood. Here, we investigated the impact of refugee mothers’ trauma exposure and mental health on their children’s mental health and attention biases to emotional expressions.